MedPath

Application of remifentanil to intravenous sedation in the patients compromised with severe gag reflex

Not Applicable
Conditions
gag reflex in dental procedure
Registration Number
JPRN-UMIN000025898
Lead Sponsor
Depertment of perioperative Medicine, Division of Anesthesiology,Showa University School of Dentistry
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
48
Inclusion Criteria

Not provided

Exclusion Criteria

Exclusion criteria included allergies to remifentanil, fentanyl-related, propofol and midazolam, used than other analgesic drug and sedative drug propofol and remifentanil, ASA class 3 or over, child and disability person.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient and dentist satisfaction by using remifentanil in intravenous sedation
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath